<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T16:16:09Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10256/16737" metadataPrefix="didl">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10256/16737</identifier><datestamp>2024-05-22T11:20:24Z</datestamp><setSpec>com_2072_452966</setSpec><setSpec>com_2072_2054</setSpec><setSpec>col_2072_452968</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
   <d:DIDLInfo>
      <dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2024-05-22T11:20:24Z</dcterms:created>
   </d:DIDLInfo>
   <d:Item id="hdl_10256_16737">
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10256/16737</dii:Identifier>
         </d:Statement>
      </d:Descriptor>
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
               <dc:title>Role of Peguero Lo-Presti criteria in the differential diagnosis between hypertrophic cardiomyopathy and hypertensive heart disease</dc:title>
               <dc:creator>Gómez Fernández, Paula</dc:creator>
               <dc:subject>Electrocardiografia</dc:subject>
               <dc:subject>Electrocardiography</dc:subject>
               <dc:subject>Cor -- Malalties -- Diagnòstic</dc:subject>
               <dc:subject>Heart -- Diseases -- Diagnosis</dc:subject>
               <dc:subject>Mort sobtada</dc:subject>
               <dc:subject>Sudden death</dc:subject>
               <dc:description>BACKGROUND: Electrocardiogram is an easy tool to determinate left ventricular&#xd;
hypertrophy, but classical criteria have a low sensitivity. A new ECG criteria, Peguero-Lo&#xd;
Presti has demonstrated in patients with Hypertensive Heart Disease (HHD) that it is more&#xd;
sensible.&#xd;
Hypertrophic Cardiomyopathy (HCM) is characterized by an heterogenous clinical and&#xd;
phenotypic expression that it is responsible of the mayor number of deaths in young people&#xd;
due to its arrhythmogenic capacity and sudden cardiac death. Moreover, more of patients&#xd;
are asymptomatic in early phases of the disease which makes very necessary to determinate&#xd;
a very sensible marker of this disease to make an early diagnosis and avoid these fatal&#xd;
consequences.&#xd;
&#xd;
HYPOTHESES: Peguero-Lo Presti criteria is more sensible to detect HCM than Sokolow-&#xd;
Lyon voltage index. Moreover, due to the different hypertrophic pattern in HHD (concentric&#xd;
&#xd;
and symmetrical hypertrophy) and HCM (asymmetrical septal hypertrophy), Peguero-Lo&#xd;
Presti criteria could have a different expression reflected on the 12-lead ECG.&#xd;
OBJECTIVES: The main of this study is to determinate the sensitivity of Peguero-Lo Presti&#xd;
criteria in patients with HCM and evaluate the role of this criteria in the differential diagnosis&#xd;
between HHD and HCM.&#xd;
METHODS: A prospective analytic and observational case-control study will be designed.&#xd;
The case-group will be formed by 185 patients with HCM and the control-group will be formed&#xd;
by 185 patients with HHD. This study will be developed at Josep Trueta Hospital in Girona&#xd;
for the Cardiology Department for 2 years</dc:description>
               <dc:date>2024-05-22T11:20:24Z</dc:date>
               <dc:date>2024-05-22T11:20:24Z</dc:date>
               <dc:date>2018-11</dc:date>
               <dc:type>info:eu-repo/semantics/bachelorThesis</dc:type>
               <dc:identifier>http://hdl.handle.net/10256/16737</dc:identifier>
               <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
               <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
               <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
               <dc:source>Medicina (TFG)</dc:source>
            </oai_dc:dc>
         </d:Statement>
      </d:Descriptor>
   </d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>